Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralipid in Repeated Implantation Failure
NCT01540591Phase 3Completed
- Sponsor
- Cairo University
- Start
- Feb 2012
- Primary completion
- Sep 2013
- Modality
- Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of Intralipid 10% in infertility (2 arms), sponsored by Cairo University. Primary endpoint: Clinical Pregnancy Rate at 10 months. Started Feb 2012; status: completed.
02
Drugs
Intralipid 10%
03
Conditions
infertility
Beyond the preview
Go deeper on NCT01540591.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01540591.